Why Wave Life Sciences Stock Vaulted 146% Higher on Monday

Even in the volatile biotech sector, it's rare for a company's stock price to more than double in a single trading session. This is what made Monday so memorable for Wave Life Sciences (NASDAQ: WVE), which trumpeted a significant advancement in a white-hot segment of the pharmaceutical industry and was rewarded by Mr. Market with a 146% increase in its share price. Before market open, Wave presented interim data from a phase 1 clinical trial of its WVE-007 weight loss drug. The treatment was found to reduce total body fat in its recipients by 4.5% over the three-month trial period. By comparison, there were no statistically meaningful changes in patients administered a placebo. Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool